01 INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT (4)
01 NOVO NORDISK INC (4)
01 INJECTABLE;SUBCUTANEOUS (4)
01 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) (1)
02 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) (2)
03 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML) (1)
01 USA (4)
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21172 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLOG MIX 70/30 PENFILL INJECTABLE;SUBCUTANEOUS, medication with 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.
18
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21172 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLOG MIX 70/30 PENFILL INJECTABLE;SUBCUTANEOUS, medication with 210 UNITS/3ML;90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.
17
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21172 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLOG MIX 70/30 INJECTABLE;SUBCUTANEOUS, medication with 700 UNITS/10ML; 300 UNITS/10ML (70 UNITS/ML; 30 UNITS/ML) of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.
16
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT, with a corresponding application number 21172 and regulatory information .
proudly manufactured in the
Novo Nordisk's NOVOLOG MIX 70/30 FLEXPEN INJECTABLE;SUBCUTANEOUS, medication with 210 UNITS/3ML; 90 UNITS/3ML (70 UNITS/ML; 30 UNITS/ML) of INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT.